feed,title,long_url,short_url
Benzinga,"FDA Rejects Rocket Pharmaceuticals' Gene Therapy For Rare Immune Disorder, Asks For More Data, Stock Slides",https://benzinga.com/general/biotech/24/06/39549390/fda-rejects-rocket-pharmaceuticals-gene-therapy-for-rare-immune-disorder-asks-for-more-data-stock,https://da.gd/lpuDl
